Lv5
1020 积分 2022-05-04 加入
Iodomethyl Methyl Ether
9小时前
待确认
POLQ to the rescue for double-strand break repair during mitosis
1个月前
已完结
mus308 mutants of Drosophila exhibit hypersensitivity to DNA cross-linking agents and are defective in a deoxyribonuclease
2个月前
已关闭
Hydrophobic Tag Tethering Degradation, The Emerging Targeted Protein Degradation Strategy
4个月前
已完结
Molecular Generation, QSAR, and Molecular Dynamic Simulation Studies for Virtual Screening of DNA Polymerase Theta Inhibitors
5个月前
已完结
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019-June 2023
6个月前
已完结
Synthetic lethality: targeting SMARCA2 ATPase in SMARCA4-deficient tumors – a review of patent literature from 2019–30 June 2023
6个月前
已完结
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019-June 2023
6个月前
已完结
The therapeutic potential of PROTACs
8个月前
已完结
The cGAS-Ku80 complex regulates the balance between two end joining subpathways
8个月前
已完结
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
4个月前
已采纳
Phase 1/2 trial of XPO1 inhibitor selinexor plus docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer
4个月前
已采纳
Data from Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study
4个月前
已采纳
Circulating Estrogen Metabolites and Risk of Breast Cancer among Postmenopausal Women in the Nurses’ Health Study
4个月前
已采纳
Bruton Tyrosine Kinase Degraders in B-Cell Malignancies
7个月前
已采纳
Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling
7个月前
已采纳
Tumor-agnostic genomic and clinical analysis of BRAF fusions identify actionable targets
9个月前
已采纳
Tumor-agnostic genomic and clinical analysis of BRAF fusions identify actionable targets
9个月前
已采纳
Iron boosts anti-tumor type 1 T-cell responses and anti-PD1 immunotherapy
9个月前
已采纳
MLLT6/ATF2 axis restrains breast cancer progression by driving DDIT3/4 expression
10个月前
已采纳
皖公网安备34019202002308
